Title:
MODEL MOUSE
Document Type and Number:
Japanese Patent JP2006340602
Kind Code:
A
Abstract:
To provide a means for ascertaining the valid effect of molecular target curative medicine used in combination with immunotherapy under nonclinical conditions.
The usefulness of antitumor agent acting on EGFR combined with an immunotherapeutic agent can be nonclinically evaluated by establishing an experimental system wherein an EGFR-positive mouse tumor strain is transplanted into a nonimmunodeficient mouse as means for nonclinically ascertaining the attainment of superior synergistic effect of joint use of tyrosine kinase inhibitor and immunotherapy such as IL-12 production inducer on cancer treatment.
Inventors:
YAGITA AKIKUNI
Application Number:
JP2003169152A
Publication Date:
December 21, 2006
Filing Date:
June 13, 2003
Export Citation:
Assignee:
ORIENT CANCER THERARY KK
International Classes:
A01K67/027; G01N33/15; G01N33/50; G01N33/566
Attorney, Agent or Firm:
Takashi Shoji